Furthermore, a functional variant in the NKX3.1 gene was associated with the increased risk of prostate cancer in subjects from the Selenium and Vitamin E Cancer Prevention Trial (SELECT)35. The gene discussed is NKX3-1; the disease is prostate carcinoma.